A biotechnology view of glycobiology.
Vapnek
D
D
D001709:Biotechnology; D004921:Erythropoietin / Q000627:therapeutic use; D006023:Glycoproteins / Q000627:therapeutic use*; D006801:Humans; D007880:Legislation, Drug; D009965:Orphan Drug Production; D014481:United States; D014486:United States Food and Drug Administration
D006023:Glycoproteins; D004921:Erythropoietin